latest news releases from the newsroom
Xenova Group PLC
Xenova Group PLC -- Tariquidar Phase I Paediatric Study Data Presented at ASCO
SLOUGH, U.K., June, 7 2004 (PRIMEZONE) -- Xenova Group plc (LSE:XEN) (Nasdaq:XNVA) announced today that the Paediatric Oncology Branch of the National Cancer Institute (NCI) in Bethesda, U.S., yesterday presented a poster at the American Society of Clinical Oncology (ASCO) conference in New Orleans, Louisiana on the paediatric Phase I clinical trial of tariquidar in children with solid tumours.
Galapagos Reports Success in Identification and Validation of Proprietary Drug Targets and Moves into Drug Discovery
MECHELEN, Belgium, June 7, 2004 (PRIMEZONE) -- Galapagos Genomics NV, Europe's leading target discovery company, announced today that it has identified, validated and filed patent applications on several novel drug targets in Alzheimer's disease, osteoporosis, osteoarthritis, rheumatoid arthritis and asthma. Galapagos has recently initiated small molecule drug development programs based on these proprietary targets. In order to expedite the building of chemistry programs around its target portfolio, Galapagos has recruited Dr. Philip Huxley as Senior Director of Drug Discovery. Galapagos uses its adenoviral based over-expression (FLeXSelect(TM)) and siRNA knock-down (SilenceSelect(TM)) collections to identify genes that modulate selected diseases in human cell models. In addition to applications in its core disease areas, Galapagos provides access to its discovery technology to a number of corporate partners. Galapagos delivers its partners validated targets that are drugable, disease modifying, and ready to be taken into small molecule screens.
Millicom International Cellular
Millicom International Cellular: Notice Of General Meeting Of Shareholders
BERTRANGE, Luxembourg, June 5, 2004 (PRIMEZONE) -- Millicom International Cellular S.A. ("Millicom") (Nasdaq:MICC) (Stockholmsborsen: MIC), today announces that, in consideration of the quorum required by law not having been reached at the annual general meeting of shareholders of MILLICOM INTERNATIONAL CELLULAR S.A. (the "Company") held on May 25, 2004 to consider and vote on the below agenda item, a second general meeting of shareholders of the Company will be held at the registered office of the Company on July 7, 2004 at 2.30 p.m. to consider and vote on the following resolution: